IMMUNOGENEOUS PRODUCT COMPRISING IL-4 AND / OR IL-13 FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND / OR IL-13 EXPRESSION OR ACTIVITY

MA52748AUndetermined Publication Date: 2021-06-02INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA52748
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-01-04
Filing Date
2019-05-29
Publication Date
2021-06-02
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.